Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA-11 PET vs mpMRI in Newly Diagnosed Prostate Cancer
NCT07209878Phase 3Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Jan 2020
- Primary completion
- Dec 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by The First Hospital of Fujian Medical University. Started Jan 2020; status: recruiting.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07209878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07209878.